Zdrowie i gospodarka · 29/12/2022
FDA Classifies Extracorporeal System for Carbon Dioxide Removal into Class II Special Controls
The FDA has classified the extracorporeal system for carbon dioxide removal into Class II special controls, aiming to ensure the device's safety and effectiveness while enhancing patients' access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →